Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells

Overview

Journal Stem Cell Rev Rep

Publisher Springer

Specialty Cell Biology

Date 2021 Mar 17

PMID 33728560

Citations 9

Authors

Gustavo Ulises Martinez-Ruiz

Abigail Morales-Sanchez

Angel Francisco Pacheco-Hernandez

Affiliations

Soon will be listed here.

Abstract

Accumulating evidence strongly indicates that the presence of cancer stem cells (CSCs) leads to the emergence of worse clinical scenarios, such as chemo- and radiotherapy resistance, metastasis, and cancer recurrence. CSCs are a highly tumorigenic population characterized by self-renewal capacity and differentiation potential. Thus, CSCs establish a hierarchical intratumor organization that enables tumor adaptation to evade the immune response and resist anticancer therapy. YY1 functions as a transcription factor, RNA-binding protein, and 3D chromatin regulator. Thus, YY1 has multiple effects and regulates several molecular processes. Emerging evidence indicates that the development of lethal YY1-mediated cancer phenotypes is associated with the presence of or enrichment in cancer stem-like cells. Therefore, it is necessary to investigate whether and to what extent YY1 regulates the CSC phenotype. Since CSCs mirror the phenotypic behavior of stem cells, we initially describe the roles played by YY1 in embryonic and adult stem cells. Next, we scrutinize evidence supporting the contributions of YY1 in CSCs from a number of various cancer types. Finally, we identify new areas for further investigation into the YY1-CSCs axis, including the participation of YY1 in the CSC niche.

Citing Articles

Overexpression of miR-192 Inhibits In Vitro Porcine Embryo Development by Inducing Oxidative Stress Damage and Impairing Mitochondrial Function.

He F, Li M, Chen F, Zhou R, Qi M, Fu B Animals (Basel). 2025; 15(1.

PMID: 39794989 PMC: 11718968. DOI: 10.3390/ani15010046.

Identification of novel nutrient sensitive human yolk sac functions required for embryogenesis.

White M, Arif-Pardy J, Bloise E, Connor K Sci Rep. 2024; 14(1):29734.

PMID: 39613845 PMC: 11607434. DOI: 10.1038/s41598-024-81061-2.

Anti-miR-141-3p maintains homeostasis between autophagy and apoptosis by targeting Yy1 in the fetal lumbosacral defecation center of rats.

Li Y, Liu P, Yao Y, Wang W, Jia H, Bai Y Mol Ther Nucleic Acids. 2024; 35(2):102163.

PMID: 38545620 PMC: 10965809. DOI: 10.1016/j.omtn.2024.102163.

Identification of the DNA methylation signature of Mowat-Wilson syndrome.

Caraffi S, van der Laan L, Rooney K, Trajkova S, Zuntini R, Relator R Eur J Hum Genet. 2024; 32(6):619-629.

PMID: 38351292 PMC: 11153515. DOI: 10.1038/s41431-024-01548-4.

Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis.

Baritaki S, Zaravinos A Cancers (Basel). 2023; 15(20).

PMID: 37894300 PMC: 10605344. DOI: 10.3390/cancers15204932.

References

Shrivastava A, Saleque S, Kalpana G, Artandi S, Goff S, Calame K . Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science. 1993; 262(5141):1889-92. DOI: 10.1126/science.8266081. View

Butti R, Gunasekaran V, Kumar T, Banerjee P, Kundu G . Breast cancer stem cells: Biology and therapeutic implications. Int J Biochem Cell Biol. 2018; 107:38-52. DOI: 10.1016/j.biocel.2018.12.001. View

Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N . Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016; 7:13616. PMC: 5150648. DOI: 10.1038/ncomms13616. View

Chen F, Zhou J, Li Y, Zhao Y, Yuan J, Cao Y . YY1 regulates skeletal muscle regeneration through controlling metabolic reprogramming of satellite cells. EMBO J. 2019; 38(10). PMC: 6518041. DOI: 10.15252/embj.201899727. View

Grosselin K, Durand A, Marsolier J, Poitou A, Marangoni E, Nemati F . High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer. Nat Genet. 2019; 51(6):1060-1066. DOI: 10.1038/s41588-019-0424-9. View

Zhao G, Li Q, Wang A, Jiao J . YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis. J Exp Clin Cancer Res. 2015; 34:66. PMC: 4511530. DOI: 10.1186/s13046-015-0177-y. View

Meliala I, Hosea R, Kasim V, Wu S . The biological implications of Yin Yang 1 in the hallmarks of cancer. Theranostics. 2020; 10(9):4183-4200. PMC: 7086370. DOI: 10.7150/thno.43481. View

Waters M, Gupta A, Mockenhaupt K, Brown L, Biswas D, Kordula T . RelB acts as a molecular switch driving chronic inflammation in glioblastoma multiforme. Oncogenesis. 2019; 8(6):37. PMC: 6541631. DOI: 10.1038/s41389-019-0146-y. View

Beagan J, Duong M, Titus K, Zhou L, Cao Z, Ma J . YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment. Genome Res. 2017; 27(7):1139-1152. PMC: 5495066. DOI: 10.1101/gr.215160.116. View

10.

Yang W, Feng B, Meng Y, Wang J, Geng B, Cui Q . FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1. J Cell Mol Med. 2019; 23(5):3464-3475. PMC: 6484506. DOI: 10.1111/jcmm.14243. View

11.

Li J, Song J, Bell R, Tran T, Haq R, Liu H . YY1 regulates melanocyte development and function by cooperating with MITF. PLoS Genet. 2012; 8(5):e1002688. PMC: 3342948. DOI: 10.1371/journal.pgen.1002688. View

12.

Britton K, Kirby J, Lennard T, Meeson A . Cancer stem cells and side population cells in breast cancer and metastasis. Cancers (Basel). 2013; 3(2):2106-30. PMC: 3757406. DOI: 10.3390/cancers3022106. View

13.

Johnston M, Maini P, Chapman S, Edwards C, Bodmer W . On the proportion of cancer stem cells in a tumour. J Theor Biol. 2010; 266(4):708-11. DOI: 10.1016/j.jtbi.2010.07.031. View

14.

Weintraub A, Li C, Zamudio A, Sigova A, Hannett N, Day D . YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 2017; 171(7):1573-1588.e28. PMC: 5785279. DOI: 10.1016/j.cell.2017.11.008. View

15.

Alvero A, Montagna M, Holmberg J, Craveiro V, Brown D, Mor G . Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther. 2011; 10(8):1385-93. PMC: 3703662. DOI: 10.1158/1535-7163.MCT-11-0023. View

16.

Xia P, Xu X . PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015; 5(5):1602-9. PMC: 4497429. View

17.

Li H, Li T, Huang D, Zhang P . Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway. Cancer Cell Int. 2020; 20:29. PMC: 6988207. DOI: 10.1186/s12935-019-1088-3. View

18.

Tang B, Raviv A, Esposito D, Flanders K, Daniel C, Nghiem B . A flexible reporter system for direct observation and isolation of cancer stem cells. Stem Cell Reports. 2014; 4(1):155-169. PMC: 4297872. DOI: 10.1016/j.stemcr.2014.11.002. View

19.

Berube-Simard F, Prudhomme C, Jeannotte L . YY1 acts as a transcriptional activator of Hoxa5 gene expression in mouse organogenesis. PLoS One. 2014; 9(4):e93989. PMC: 3976385. DOI: 10.1371/journal.pone.0093989. View

20.

Paranjape A, Mandal T, Mukherjee G, Kumar M, Sengupta K, Rangarajan A . Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Oncogene. 2011; 31(15):1896-909. DOI: 10.1038/onc.2011.378. View